Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Butylphthalide Soft Capsules for Secondary Prevention of Ischemic Stroke (Real-World Study)
ChiCTR2000034481Phase 4Not yet recruiting
- Sponsor
- Northwestern University
- Start
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of butylphthalide in ischemic stroke (2 arms), sponsored by Northwestern University. Primary endpoint: Recurrence rate of stroke. Planned start Jul 2020; status: not yet recruiting.
02
Drugs
butylphthalide
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on ChiCTR2000034481.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000034481.